Patent Application
Utility
PCT National Stage
App. No. 14/416,229
· Confirmation No. 1082
OPHTHALMIC COMPOSITIONS WITH WAX ESTERS
Inventor:
Martin J. Coffey
Applicant:
Bausch & Lomb Incorporated
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2016-08-11 | ABN |
Abandonment | 2 | View | |
| 2016-01-06 | CTNF |
Non-Final Rejection | 6 | View | |
| 2016-01-06 | 1449 |
List of References cited by applicant and considered by examiner | 5 | View | |
| 2016-01-06 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2015-07-23 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2015-05-01 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2015-05-01 | ADS |
Application Data Sheet | 7 | View | |
| 2015-05-01 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2015-04-13 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2015-04-13 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2015-04-13 | WCLM |
Claims Worksheet (PTO-2022) | 1 | View | |
| 2015-04-13 | M903 |
Notice of Designated Office (DO) / Elected Office (EO) Acceptance Mailed | 2 | View | |
| 2015-02-17 | OATH |
Oath or Declaration filed | 4 | View | |
| 2015-01-21 | TRNA |
Transmittal of New Application | 4 | View | |
| 2015-01-21 | ADS |
Application Data Sheet | 7 | View | |
| 2015-01-21 | A.PE |
Preliminary Amendment | 1 | View | |
| 2015-01-21 | CLM |
Claims | 4 | View | |
| 2015-01-21 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2015-01-21 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 5 | View | |
| 2015-01-21 | FOR |
Foreign Reference | 17 | View | |
| 2015-01-21 | FOR |
Foreign Reference | 32 | View | |
| 2015-01-21 | FOR |
Foreign Reference | 44 | View | |
| 2015-01-21 | REF.OTHER |
Other reference-Patent/Application/Search Documents | 12 | View | |
| 2015-01-21 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2015-01-21 | N417 |
Electronic Filing System Acknowledgment Receipt | 4 | View | |
| 2015-01-21 | 371P |
Documents submitted with 371 (National Stage) Applications | 1 | View | |
| 2015-01-21 | FRPR |
Certified Copy of Foreign Priority Application | 45 | View | |
| 2015-01-21 | P.N.101.CONV |
PCT/RO/101 - Request form for new International Application - Conventional | 4 | View | |
| 2015-01-21 | ABST |
Abstract | 1 | View | |
| 2015-01-21 | SPEC |
Specification | 24 | View | |
| 2015-01-21 | CLM |
Claims | 3 | View |
Inventors
Martin J. Coffey
Buffalo Grove, IL
Attorneys & Agents of Record
Classification
USPC
514/772.6
A61K47/44
A61K9/0048
A61K31/56
A61K47/24
A61K47/32
Prosecution
- Examiner
- FAY, ZOHREH ALEMZADEH
- Art Unit
- 1621
- Customer No.
- 23702
- Docket No.
- P05533-US (13799.000908)
- Confirmation No.
- 1082
Publication
- Pub. No.
- US20150202306A1
- Pub. Date
- 2015-07-23
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSH & LOMB PHARMA HOLDINGS CORP.,
DENDREON PHARMACEUTICALS, INC.,
DOW PHARMACEUTICAL SCIENCES, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
OBAGI MEDICAL PRODUCTS, INC.,
OMP, INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
VALEANT CANADA LP, BY ITS GENERAL PARTNER VALEANT CANADA GP LIMITED,
VALEANT HOLDINGS IRELAND (AS SUCCESSOR TO VALEANT INTERNATIONAL BERMUDA),
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC
SECURITY INTEREST
Recorded 2016-07-18
from
COFFEY, MARTIN J.
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2015-02-17
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 14/416,229
- Filed
- 2015-01-21
- Pub. No.
- US20150202306A1
- Examiner
- FAY, ZOHREH ALEMZADEH
- Art Unit
- 1621
External Links